Suppr超能文献

在接受三钾二枸橼酸铋治疗的患者中,D-青霉胺不会增加尿铋排泄。

D-penicillamine does not increase urinary bismuth excretion in patients treated with tripotassium dicitrato bismuthate.

作者信息

Nwokolo C U, Pounder R E

机构信息

Academic Department of Medicine, Royal Free Hospital School of Medicine, London.

出版信息

Br J Clin Pharmacol. 1990 Oct;30(4):648-50. doi: 10.1111/j.1365-2125.1990.tb03829.x.

Abstract

Twenty-four urinary bismuth excretion was measured in five patients who had been treated with tripotassium dicitrato bismuthate, before and after single 1 g oral dose of D-penicillamine. Before dosing with D-penicillamine, the median 24 h urinary bismuth output was 55 micrograms 24 h-1 (range 17-156 micrograms 24 h-1) and following dosing with D-penicillamine the median 24 h urinary bismuth output was 53 micrograms 24 h-1 (range 12-156 micrograms 24 h-1). D-penicillamine does not facilitate the urinary excretion of bismuth, hence it is unsuitable for use as an oral chelator in patients with bismuth intoxication.

摘要

在5例曾用三钾二枸橼酸铋治疗的患者中,测定了单次口服1g D-青霉胺前后24小时尿铋排泄量。在给予D-青霉胺之前,24小时尿铋排泄量中位数为55微克/24小时(范围17 - 156微克/24小时),给予D-青霉胺后,24小时尿铋排泄量中位数为53微克/24小时(范围12 - 156微克/24小时)。D-青霉胺不能促进铋的尿排泄,因此它不适用于铋中毒患者作为口服螯合剂使用。

相似文献

1
D-penicillamine does not increase urinary bismuth excretion in patients treated with tripotassium dicitrato bismuthate.
Br J Clin Pharmacol. 1990 Oct;30(4):648-50. doi: 10.1111/j.1365-2125.1990.tb03829.x.
2
3
Bismuth accumulates in the body during treatment with tripotassium dicitrato bismuthate.
Aliment Pharmacol Ther. 1989 Feb;3(1):21-8. doi: 10.1111/j.1365-2036.1989.tb00187.x.
4
Omeprazole-induced increase in the absorption of bismuth from tripotassium dicitrato bismuthate.
Clin Pharmacol Ther. 1994 May;55(5):486-91. doi: 10.1038/clpt.1994.61.
5
The absorption of bismuth from oral doses of tripotassium dicitrato bismuthate.
Aliment Pharmacol Ther. 1989 Feb;3(1):29-39. doi: 10.1111/j.1365-2036.1989.tb00188.x.
6
Studies on the absorption and excretion of tripotassium dicitrato-bismuthate in man.
Res Commun Chem Pathol Pharmacol. 1981 Nov;34(2):359-64.
7
Lack of evidence of neurotoxicity following 8 weeks of treatment with tripotassium dicitrato bismuthate.
Aliment Pharmacol Ther. 1994 Feb;8(1):45-53. doi: 10.1111/j.1365-2036.1994.tb00159.x.
8
Comparison of plasma bismuth levels after oral dosing with basic bismuth carbonate or tripotassium dicitrato bismuthate.
Aliment Pharmacol Ther. 1992 Apr;6(2):241-9. doi: 10.1111/j.1365-2036.1992.tb00267.x.

本文引用的文献

1
Antidotes for acute bismuth intoxication.
J Toxicol Clin Toxicol. 1983 Apr;20(2):159-65. doi: 10.3109/15563658308990060.
2
DMSA and DMPS--water soluble antidotes for heavy metal poisoning.
Annu Rev Pharmacol Toxicol. 1983;23:193-215. doi: 10.1146/annurev.pa.23.040183.001205.
3
Reversible encephalopathy possibly associated with bismuth subgallate ingestion.
Br Med J. 1974 Feb 9;1(5901):220-3. doi: 10.1136/bmj.1.5901.220.
4
Dose of influenza virus subunit vaccine.
Med J Aust. 1973 May 5;1(18):912-3. doi: 10.5694/j.1326-5377.1973.tb110788.x.
7
The clinical significance of Campylobacter pylori.
Ann Intern Med. 1988 Jan;108(1):70-9. doi: 10.7326/0003-4819-108-1-70.
8
Neuropsychiatric symptoms following bismuth intoxication.
Postgrad Med J. 1988 Apr;64(750):308-10. doi: 10.1136/pgmj.64.750.308.
9
Prospective double-blind trial of duodenal ulcer relapse after eradication of Campylobacter pylori.
Lancet. 1988;2(8626-8627):1437-42. doi: 10.1016/s0140-6736(88)90929-4.
10
Myoclonic encephalopathy due to bismuth salts: treatment with dimercaprol and analysis of CSF transmitters.
Acta Neurol Scand. 1989 Mar;79(3):200-3. doi: 10.1111/j.1600-0404.1989.tb03739.x.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验